(Q34609996)

3 August 2017

title

Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria (English)

1 reference

3 August 2017

0 references

0 references

0 references

Rachel L Edwards

11

0 references

Garrett C Moraski

object named as

Garrett Moraski

5

0 references

Ute Möllmann

6

object named as

Ute Möllmann

1 reference

3 August 2017

Marvin J Miller

1

1 reference

3 August 2017

Andrew J Walz

2

1 reference

3 August 2017

Helen Zhu

3

1 reference

3 August 2017

Chunrui Wu

4

1 reference

3 August 2017

Esther M Tristani

7

1 reference

3 August 2017

Alvin L Crumbliss

8

1 reference

3 August 2017

Michael T Ferdig

9

1 reference

3 August 2017

Lisa Checkley

10

1 reference

3 August 2017

Helena I Boshoff

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

28 January 2011

1 reference

Journal of the American Chemical Society

3 August 2017

published in

1 reference

3 August 2017

volume

133

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

2076-2079

1 reference

Maximizing bactericidal activity with combinations of bioreduced drugs

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Chemistry and biology of siderophores

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Siderophore-based iron acquisition and pathogen control

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

A common mechanism of cellular death induced by bactericidal antibiotics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Iron, mycobacteria and tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Clinical status and implications of antimalarial drug resistance.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Screening system for xenosiderophores as potential drug delivery agents in mycobacteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Iron chelators from mycobacteria (1954-1999) and potential therapeutic applications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Clinical studies of iron chelators in malaria.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Tuberculosis & malaria. Landscapes of infection. Introduction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Synthesis of O-aminodihydroartemisinin via TMS triflate catalyzed C-O coupling reaction

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045749

Hemin-catalyzed decomposition of artemisinin (qinghaosu)

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21275374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tuberculosis, a neglected opportunity?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21275374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/JA109665T

1 reference

3 August 2017

1 reference

3 August 2017

1 reference